Drug Profile


Alternative Names: CS-830; Reona; TS-410

Latest Information Update: 08 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Taisho Pharmaceutical
  • Class Anti-inflammatories; Corticosteroids
  • Mechanism of Action Arachidonic acid inhibitors; Cyclooxygenase inhibitors; Lipocortin synthesis agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Skin disorders

Most Recent Events

  • 08 Nov 2006 Discontinued - Preregistration for Skin disorders in Japan (Topical)
  • 11 Sep 2000 No-Development-Reported for Skin disorders in Japan (Topical)
  • 04 Mar 1997 Preregistration for Skin disorders in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top